Companies: 10,795·Total market cap: $144.5T
Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATHENASDAQHealthcare● Active
$3.92
+$0.02(+0.46%)
Market Cap$35534263
P/E Ratio
52W High$7
52W Low$2.66

Alterity Therapeutics Limited(ATHE)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

athe · 股价预测 · 8 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

SellBuy

Buy

8 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
4
Sell
0
Strong Sell
0
合计: 8 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.92

Alterity Therapeutics Limited(ATHE)的分析师共识为 Buy,基于过去 3 个月内 8 位华尔街分析师的评级。ATHE 的 12 个月平均目标价为 $0.00,相对当前价 $3.92 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.773.94%

1-day model range: $3.74–$3.79. Peak: $3.79 (-3.94%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-41.2%
2028$2-53.3%
2029$2-58.1%
2030$2-60.3%
2031-61.3%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

21%0%79%
3Buy
0Neutral
11Sell
RSI (14)15.0Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ATHE · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.95SELL
MA 10$4.01SELL
MA 20$4.21SELL
MA 50$4.18SELL
MA 100$3.79BUY
MA 200$3.91BUY
Current $ATHE · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.95SELL
EMA 10$4.02SELL
EMA 20$4.13SELL
EMA 50$4.10SELL
EMA 100$3.97SELL
EMA 200$3.93SELL
Current $ATHE · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Maxim Group2025-01-30
Maintains
BuyBuy
Benchmark2024-03-07
Maintains
Speculative BuySpeculative Buy
Ladenburg Thalmann2023-06-05
Maintains
BuyBuy
Ladenburg Thalmann2022-08-03
Maintains
BuyBuy
Goldman Sachs2022-06-23
Maintains
NeutralNeutral
Benchmark2021-08-20
Maintains
Speculative BuyBuy
B. Riley FBR2018-01-05
Maintains
BuyBuy
H.C. Wainwright2014-03-31
Downgrade ↓
BuyNeutral
MLV & Co.2014-03-31
Downgrade ↓
BuyHold
H.C. Wainwright2014-02-26
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Alterity Therapeutics Limited (ATHE) stock. Of the recent 12 rating actions, 0 were upgrades and 2 were downgrades. 8 analysts currently cover ATHE.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ATHE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$5M

↓ 47.6% YoY

Revenue Next Year

$3M

↓ 51.2% YoY

EPS This Year

$-0.72

EPS Next Year

$-0.89

↑ 23.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ATHE EPS of $-0.72 for the current fiscal year, based on estimates from 1 analysts. The ATHE revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ATHE 股价预测由两类独立数据源支撑:来自 8 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ATHE 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

ATHE 的短期预测(明日)为 $3.77(-3.94%)。 ATHE 对 2027 年的股价预测均值为 $2。 ATHE 对 2030 年的预测区间为 $1–$2。

Alterity Therapeutics Limited 在 NASDAQ 上市,代码 ATHE。ATHE 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ATHE 预测 · 8 个问题

根据 8 位华尔街分析师,ATHE 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $3.92,隐含约 +0.0% 的上行空间。

ATHE 目标价ATHE 分析师目标价ATHE 12个月目标价目标价 ATHE

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.